Par Pharmaceutical
Par Pharmaceutical, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1978, the company has established itself as a leader in the development and manufacturing of generic and specialty pharmaceuticals. With a strong operational presence across North America, Par Pharmaceutical focuses on delivering high-quality, affordable medications that meet the needs of healthcare providers and patients alike. The company is renowned for its extensive portfolio of products, including injectables and complex generics, which are distinguished by their rigorous quality standards and innovative formulations. Par Pharmaceutical's commitment to excellence has earned it a significant market position, marked by notable achievements in regulatory compliance and product development. As a trusted partner in the healthcare sector, Par Pharmaceutical continues to advance its mission of improving patient outcomes through accessible medication solutions.
DitchCarbon Score
How does Par Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Par Pharmaceutical's score of 3 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Par Pharmaceutical's reported carbon emissions
Par Pharmaceutical, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Par Pharmaceutical may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to adopt science-based targets to reduce greenhouse gas emissions across all scopes. As the industry evolves, it will be crucial for Par Pharmaceutical to establish clear climate goals and transparency in emissions reporting to align with global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Par Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
